Cardioprotection

Br J Haematol. 1999 Sep;106(4):860-9. doi: 10.1046/j.1365-2141.1999.01544.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Anthracyclines / adverse effects*
  • Anthracyclines / pharmacokinetics
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / pharmacokinetics
  • Heart Diseases / chemically induced*
  • Heart Diseases / prevention & control
  • Humans

Substances

  • Anthracyclines
  • Antineoplastic Agents